Search

Search Constraints

You searched for: Author/Creator Asokan, Mangaiarkarasi

Search Results

1. A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention. Issue 1 (1st January 2021)

2. Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency. Issue 1 (31st December 2023)

3. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1. (June 2018)

4. Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies. Issue 1 (1st January 2020)

5. Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies. Issue 1 (1st January 2020)

6. Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies. Issue 1 (1st January 2020)

7. Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies. Issue 1 (1st January 2020)